Metoclopramide Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 10 USDMF, 4 CEP/COS, 1 JDMF, 3 EU WC, 9 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

116 FDF Dossiers, 78 FDA Orange Book, 8 Europe, 8 Canada, 4 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Evonik, 5 Rochem International Inc, 17 SPI Pharma, 6 DKSH, 5 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 27 Kerry, 3 Lonza Capsugel, 16 Microlex e.U, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 28 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

90 Fillers, Diluents & Binders, 45 Direct Compression, 31 Disintegrants & Superdisintegrants, 24 Taste Masking, 23 Thickeners and Stabilizers, 23 Granulation, 19 Co-Processed Excipients, 18 Chewable & Orodispersible Aids, 16 Parenteral, 16 Film Formers & Plasticizers, 15 Lubricants & Glidants, 10 Controlled & Modified Release, 10 Coating Systems & Additives, 10 Solubilizers, 8 Empty Capsules, 5 Topical, 4 Emulsifying Agents, 2 API Stability Enhancers, 1 Soft Gelatin, 1 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 Finished Drug Prices

8 Finished Drug Prices

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22246 / DOSAGE - TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
METOCLOPRAMIDE HYDROCHLORIDE(UNII: W1792A2RVD) (METOCLOPRAMIDE - UNII:L4YEB44I46)	METOCLOPRAMIDE	5mg \| 10mg

Inactive Ingredients

Ingredient Name	Salix Pharmaceuticals, Inc.
ACESULFAME POTASSIUM(23OV73Q5G9)
GELATIN(2G86QN327L)
MANNITOL(3OWL53L36A)
SODIUM CHLORIDE(451W47IQ8X)
SODIUM HYDROXIDE(55X04QC32I)

Drug Product Composition: Metoclopramide Hydrochloride